Pharmacology for Nurses · Introduction to the Nervous System
Characteristics of Drugs to Treat Nervous System Disorders
On this page 9 sections
In 30 seconds
Drugs for nervous system disorders — antiseizure drugs, medications for Parkinson's and Alzheimer's disease, anesthetics, and many others — share defining characteristics. Most must cross the Blood-brain barrier (BBB) The tight cellular filter between blood and brain tissue Full entry → to reach targets inside the central nervous system (CNS). Most act at synapses, the microscopic gaps between neurons, by changing how chemical messengers (neurotransmitters) are made, released, received, or removed. And almost all have a narrow margin between a helpful dose and a harmful one, because the receptors they influence in the brain also exist elsewhere in the body.
Understand these shared features and a list of nervous system drugs becomes a predictable pattern: know how a drug enters the brain and which step of transmission it alters, and you can predict its effects and the nursing assessments it requires.
Why this matters
These are among the most commonly prescribed and dangerous medications in health care — and a frequent source of exam questions, because their mechanisms are teachable: understand neurotransmission and you can reason out almost any CNS drug. Adverse effects — sedation, falls, cardiac rhythm changes, respiratory depression — are leading causes of preventable harm, especially in older adults. Because many CNS drugs require slow titration and close monitoring, the nurse's role in assessment, education, and recognizing toxicity is central to safe therapy.
The college version
Core Concepts
Getting into the brain: the blood-brain barrier
The BBB is a filter of tightly joined capillary cells, reinforced by support cells (astrocytes) and efflux transporters that pump some drugs back out. Lipid-soluble (lipophilic) drugs cross readily; large, water-soluble, or highly protein-bound drugs generally do not — which is why CNS drug design favors lipid-soluble molecules. Efflux transporters such as P-glycoprotein can reduce effectiveness and contribute to interactions.
Where CNS drugs act: steps of synaptic transmission
Neurons communicate by releasing neurotransmitters across a Synapse The microscopic gap where a neuron signals the next cell Full entry →, and drugs can alter nearly every step:
- Synthesis and storage — changing how much Neurotransmitter A chemical messenger released at a synapse Full entry → is made or packaged.
- Release — increasing or decreasing how much is released when a nerve fires.
- Receptor binding — the most common target: mimicking the neurotransmitter (Agonist A drug that binds a receptor and activates it Full entry →), blocking it (Antagonist A drug that blocks receptor activation Full entry →), or partially activating it (partial agonist).
- Reuptake Recycling of a neurotransmitter into the releasing neuron Full entry → — blocking transporter proteins that recycle the neurotransmitter, raising its levels in the synapse.
- Enzymatic breakdown — inhibiting degradative enzymes (as cholinesterase inhibitors do for acetylcholine) prolongs the signal.
Agonists, antagonists, and receptor subtypes
An agonist binds a receptor and produces a response like the natural neurotransmitter; an antagonist blocks the signal without activating it; a partial agonist produces a weaker response than the natural ligand even when fully occupying receptors. Receptor subtypes add another layer: the same neurotransmitter activates several distinct receptor types, so a drug aimed at one subtype may unavoidably stimulate related receptors elsewhere — the root of most predictable adverse effects.
Selectivity: why CNS drugs affect the whole body
The same receptors and neurotransmitters operate in the gut, heart, lungs, and glands. A drug that raises acetylcholine in the brain also raises it in the heart (bradycardia) and gut (nausea, diarrhea). This limited selectivity explains why every CNS drug has predictable off-target effects — and why nursing assessment includes vital signs, GI status, and level of consciousness, not just the targeted symptom.
Pharmacokinetics and individual variation
CNS drugs are often lipid-soluble, so they distribute widely and are usually metabolized by liver enzymes (including the CYP450 family) and excreted by the kidneys. Interactions are common when several CNS drugs are combined — they compete for the same pathways or add together in sedative or cardiorespiratory effects. Older adults have reduced metabolism and clearance and greater fall risk, so dosing is typically started low and increased slowly. No dose is universal: therapy is individualized and verified against current references, the formulary, and prescriber orders.
Tolerance, dependence, and withdrawal
With repeated use the nervous system adapts. Tolerance means the same dose produces less effect, so larger doses may be needed. Physical dependence means abrupt discontinuation causes withdrawal — possible with many CNS drugs used legitimately. Both differ from addiction (compulsive use despite harm). Abruptly stopping many CNS drugs (antiseizure medications, benzodiazepines, some psychiatric drugs) can be dangerous, so most are tapered under prescriber direction.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| Agonist | Antagonist | An agonist activates the receptor; an antagonist blocks it — opposite jobs at the same target |
| Tolerance | Dependence | Tolerance = same dose, less effect; dependence = withdrawal if the drug stops. You can have one without the other |
| Dependence | Addiction | Dependence is physical adaptation; addiction is compulsive use despite harm |
| "Crosses the BBB" | "Works only in the brain" | A drug that enters the brain still acts on the same receptors elsewhere in the body |
| Reuptake blockade | Enzyme inhibition | Reuptake blockade stops recycling; enzyme inhibition stops breakdown — two ways to raise neurotransmitter levels |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your brain is like a secret building with a security gate (the blood-brain barrier) that only lets special messengers through. Inside, neurons pass notes across tiny gaps. Brain medicines either sneak through the gate, act like the notes (agonists), block the notes (antagonists), or change how long a note lasts. The tricky part: the same notes are used in your heart and stomach, so the medicine can change those too — that's why nurses check your pulse and ask how your stomach feels.
Worked example
Imagine a hypothetical drug described as "a lipid-soluble, reversible inhibitor of the enzyme that breaks down acetylcholine." Because it is lipid-soluble, it crosses the blood-brain barrier; because it blocks the breakdown enzyme, acetylcholine lingers wherever it is released — in the brain, but also in the heart, lungs, and gut. Your predicted adverse-effect profile includes bradycardia, bronchoconstriction, and nausea, vomiting, and diarrhea, so you would assess baseline heart rate and respiratory status before the first dose and teach the person what to report. You would not guess a dose — that comes from current references, the formulary, and the prescriber. One mechanism predicts the therapeutic effect, the toxicity, and the nursing plan.
Key takeaways
- The BBB decides access: lipid-soluble, small, largely unbound drugs reach the CNS.
- CNS drugs target steps of synaptic transmission — synthesis, storage, release, receptor binding, reuptake, or breakdown — with receptor binding the most common target.
- Agonist (activates) vs antagonist (blocks) vs partial agonist (dampened activation) is the most tested mechanistic distinction.
- Limited selectivity explains adverse effects: the same receptors exist outside the brain, so every CNS drug affects heart rate, GI motility, or other systems.
- CNS drugs are often lipid-soluble → wide distribution, liver metabolism, frequent interactions.
- "Start low and go slow" is the common pattern, especially in older adults; individualize and verify against references and orders.
- Tolerance ≠ dependence ≠ addiction; abrupt withdrawal of many CNS drugs is dangerous and requires prescriber-directed tapering.
- Nursing anchors: baseline neuro assessment, vital signs, fall risk, sedation level, and teaching what to report.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
List three properties of a drug that make it likely to cross the blood-brain barrier.
Show answer
Lipid solubility, small molecular size, and being largely unbound to plasma proteins. Efflux transporter susceptibility also matters.
A drug is described as an antagonist at a receptor. What does it do, and what does it not do?
Show answer
It binds the receptor and blocks the natural neurotransmitter from activating it, producing no direct response itself. It does not mimic the neurotransmitter; it prevents the signal.
Name three steps of synaptic transmission that drugs can modify.
Show answer
Synthesis/storage, release, receptor binding (agonists/antagonists/partial agonists), reuptake, or enzymatic breakdown — any three with a correct mechanism description are acceptable.
Why do CNS drugs so often cause effects on the heart and gastrointestinal tract?
Show answer
Because the same neurotransmitters and receptor types exist outside the brain — in the heart (rate and rhythm), lungs (bronchoconstriction), and gut (motility and secretions). The drug acts wherever that receptor lives, not only where we want it to.
A person needs a higher dose of a CNS drug for the same effect after months of use. Tolerance, dependence, or addiction? Explain.
Show answer
Tolerance — the same dose now produces less effect, an adaptive response to repeated exposure. Dependence would require a withdrawal syndrome on stopping; addiction would require compulsive use despite harm.
A nurse is preparing to give a first dose of a CNS drug. What baseline assessments are most important, and why?
Show answer
Baseline vital signs (especially heart rate and respiratory status), level of consciousness, neurological status, fall risk, and GI status — the comparison point for detecting expected adverse effects.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Blood-brain barrier (BBB)
- The tight cellular filter between blood and brain tissue
- Synapse
- The microscopic gap where a neuron signals the next cell
- Neurotransmitter
- A chemical messenger released at a synapse
- Agonist
- A drug that binds a receptor and activates it
- Antagonist
- A drug that blocks receptor activation
- Reuptake
- Recycling of a neurotransmitter into the releasing neuron
- Tolerance / Dependence
- Needing more drug for the same effect (tolerance); withdrawal on stopping (dependence)
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.